Since it was founded in 1979,
EDAP TMS has been committed to introducing new and innovative
technologies for a minimally invasive approach to treating
urological disorders.
These proprietary technologies such
as Focused Ultrasound or Piezo-electric Shockwaves have yielded
new minimally invasive procedures for the treatment of several pathologies
such as localized prostate cancer, urinary tract stones or benign
prostatic hyperplasia.
EDAP TMS’s products represent alternatives to traditional
surgical procedures that often involve high cost, significant side
effects and long recovery times.
Through its continued research and development
efforts, its expertise in clinical studies, regulatory affairs
and global marketing, EDAP TMS is ensuring cost effective
therapeutic solutions for the benefit of the patient, the
physician and the health care provider.